Table 1.
Demography and ocular findings of NMO and MS patients
| NMO | MS | P | |
|---|---|---|---|
| (n = 15) | (n = 20) | value | |
| Sex (male/female) | 0/15 | 5/15 | 0.057 |
| Age at onset | 36.0 ± 10.9 | 29.2 ± 8.8 | 0.038 |
| Duration of disease (years) | 14.4 ± 8.8 | 11.5 ± 9.9 | 0.216 |
| Number of total relapses | 10.1 ± 4.8 | 6.3 ± 6.4 | 0.007 |
| Number of ON relapses | 3.4 ± 3.2 | 1.7 ± 0.8 | 0.004 |
| EDSS score | 5.1 ± 2.5 | 2.6 ± 1.6 | 0.009 |
| Brain lesion, % (n) | 60 (9) | 90 (18) | 0.051 |
| Spinal lesion, % (n) | 100 (15) | 60 (12) | 0.005 |
| LESCL, % (n) | 87 (13) | 10 (2) | <0.001 |
| Anti-AQP4 antibody, % (n) | 100 (15 ) | 0 | <0.001 |
NMO = neuromyelitis optica; MS = multiple sclerosis; ON = optic neuritis; EDSS = expanded disability status scale; LESCL = longitudinally extensive spinal cord lesions.